CardiAQ Valve Technologies announces first implantation of TMVR
June 14, 2012: CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and...
June 14, 2012: CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and...
April 26, 2012: MiRagen Therapeutics, Inc., a biopharmaceutical company developing innovative microRNA (miRNA)-based therapeutics primarily...
January 20, 2012 Apama Medical Press Release Over the past six months, we have been...
Boulder, CO-based miRagen has racked up its first big collaboration, inking a development pact with...
CardiaLen Awarded Phase I SBIR Grant Cardiac arrhythmia start-up awarded $216,027 grant to develop a...
CardiaLen receives significant financing from Broadview Ventures CardiaLen receives significant financing from Broadview Ventures to...